| Funding Opportunity ID: | 328742 | | Opportunity Number: | ONDCP2 | | Opportunity Title: | Fiscal Year (FY) 2020 Competitive Cooperative Agreement Solicitation Combating Opioid Overdose through Community-Level Intervention | | Opportunity Category: | Discretionary | | Opportunity Category Explanation: | | | Funding Instrument Type: | Cooperative Agreement | | Category of Funding Activity: | Science and Technology and other Research and Development | | Category Explanation: | | | CFDA Number(s): | 95.007 | | Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) | | Additional Information on Eligibility: | Public nonprofit institutions/organizations (Institutions of Higher Education (Public and/or Private) Hospitals (Private nonprofit Institutions/organizations) | | Agency Code: | ONDCP | | Agency Name: | Office of National Drug Control Policy | | Posted Date: | Aug 20, 2020 | | Close Date: | Aug 26, 2020 | | Last Updated Date: | Aug 20, 2020 | | Award Ceiling: | $2,000,000 | | Award Floor: | $2,000,000 | | Estimated Total Program Funding: | | | Expected Number of Awards: | 1 | | Description: | Office of National Drug Control Policy Executive Office of the President 1800 G Street, NW Washington, DC 20503 Fiscal Year (FY) 2020 Competitive Cooperative Agreement Solicitation Combating Opioid Overdose through Community-Level Intervention Funding Opportunity Announcement (FOA) Number: Catalog of Federal Domestic Assistance (CFDA) Number: 95.007 Release Date: August 19, 2020 The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to: Undertake research activities that would entail implementing and evaluating community-based efforts to fight the opioid overdose epidemic; and Support and promote the partnership of law enforcement and public health agencies, whose collaboration is critical to reducing overdose and other harms of opioid (mis)use. Deadline Applicants must register with Grants.gov prior to submitting an application. All applications must be submitted and applicants must be in receipt of a successful validation message in Grants.gov by 5:00 p.m., Eastern Time, on August 26, 2020. If the postmark/submission date falls on a weekend, Federal holiday, or Washington, DC area Federal office closure, the application deadline will automatically be extended to the next business day. Contact Information For technical assistance with submitting an application, contact the Grants.gov Customer Support Hotline at (800) 518-4726 or (606) 545-5035, or via email to [email protected] The Grants.gov Customer Support Hotline hours of operation are 24 hours a day, 7 days a week, except Federal holidays. Applicants who experience unforeseen Grants.gov technical issues that prevent them from submitting their application by the deadline must submit all required application materials to [email protected] no later than 5:00 p.m. on August 26, 2020, via email (including a brief explanation of the technical issues that prevented application through Grants.gov) and request approval for acceptance of the separate application. For assistance with any other requirements of this solicitation, applicants may contact Jayme Delano, Office of National Drug Control Policy, by telephone at (202) 395-6794 or by email at [email protected] Eligibility Eligible Applicant Public nonprofit institutions/organizations (Institutions of Higher Education (Public and/or Private) Hospitals (Private nonprofit Institutions/organizations) Eligibility Criteria Applicants must have expert knowledge and extensive experience in conducting research and analysis. Applicants must have expert knowledge and experience developing or enhancing new or ongoing programs that aim to reduce opioid overdose through strategic, evidence-based approaches. Applicants must partner with a regional High Intensity Drug Trafficking Area (HIDTA) program, and applications must include a letter of support/commitment from the participating HIDTA and signed by the sponsoring HIDTA Director. In order to be eligible to receive funding under this award, recipients must be legally recognized as a public or private nonprofit institution/organization (includes institutions of higher education and hospitals). | | Version: | 1 |
|
